Innovation Cheque from Comunidad de Madrid 2020. UCS-Aptameros from IRYCIS-Hospital Ramón y Cajal will perform the study of biodistribution of aptamer agonist of MNK1 receptor in a number of tissues. These data will be used in the design of the clinical trials for breast cancer treatment.
